Prophylactic Antipyretic Treatment in Children Receiving Booster Dose of Pneumococcal Vaccine GSK1024850A and DTPa-HBV-IPV/Hib Vaccine (Infanrix Hexa) and Assessment of Impact of Pneumococcal Vaccination on Nasopharyngeal Carriage
Latest Information Update: 07 Sep 2023
At a glance
- Drugs Pneumococcal 10-valent vaccine conjugate (Primary) ; Hib DTaP hepatitis B poliovirus vaccine (Infanrix hexa); Meningococcal vaccine groups A B C Y W-135 conjugate; Meningococcal vaccine groups A C Y W-135 conjugate; Paracetamol; RIX 4414
- Indications Diphtheria; Fever; Haemophilus infections; Hepatitis B; Meningococcal group A infections; Meningococcal group B infections; Meningococcal group C infections; Meningococcal group W-135 infections; Meningococcal infections; Pertussis; Pneumococcal infections; Rotavirus infections; Tetanus
- Focus Adverse reactions; Therapeutic Use
- Sponsors GlaxoSmithKline; GSK
- 28 Mar 2013 New trial record